» Authors » Hansen J Kosasih

Hansen J Kosasih

Explore the profile of Hansen J Kosasih including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 74
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Beck D, Cao H, Tian F, Huang Y, Jiang M, Zhao H, et al.
Nat Commun . 2024 Nov; 15(1):9697. PMID: 39516193
The epigenetic landscape plays a critical role in cancer progression, yet its therapeutic potential remains underexplored. Glucocorticoids are essential components of treatments for lymphoid cancers, but resistance, driven in part...
2.
Toscan C, McCalmont H, Ashoorzadeh A, Lin X, Fu Z, Doculara L, et al.
Blood Cancer J . 2024 Nov; 14(1):192. PMID: 39505850
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that expresses high levels of the enzyme aldo-keto reductase family 1 member C3 (AKR1C3). To exploit this finding, we developed...
3.
Kosasih H, de Bock C
Hemasphere . 2024 Jul; 8(7):e125. PMID: 39035108
No abstract available.
4.
Kosasih H, Healey G, Brennan M, Bjelosevic S, Sadras T, Jalud F, et al.
Hemasphere . 2024 Mar; 8(2):e1. PMID: 38435422
No abstract available.
5.
Randall J, Evans K, Watts B, Kosasih H, Smith C, Earley E, et al.
Exp Hematol . 2024 Feb; 132:104176. PMID: 38320689
The overall survival rate of patients with T-cell acute lymphoblastic leukemia (T-ALL) is now 90%, although patients with relapsed T-ALL face poor prognosis. The ubiquitin-proteasome system maintains normal protein homeostasis,...
6.
Omari S, Kosasih H, Chung T, de Bock C
Heliyon . 2023 Dec; 9(11):e22085. PMID: 38053908
Mutations within the IL7-R-JAK-STAT signaling pathway are important drivers of T-cell acute lymphoblastic leukemia (T-ALL). Here we describe the important steps required to generate retroviral particles for the stable expression...
7.
De Coninck S, De Smedt R, Lintermans B, Reunes L, Kosasih H, Reekmans A, et al.
Haematologica . 2023 Nov; 109(5):1373-1384. PMID: 37941480
T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) are rare aggressive hematologic malignancies. Current treatment consists of intensive chemotherapy leading to 80% overall survival but is associated with...
8.
Gu A, Schmidt B, Lonsdale A, Jalaldeen R, Kosasih H, Brown L, et al.
Blood Adv . 2023 Oct; 7(24):7402-7406. PMID: 37903323
No abstract available.
9.
Sadras T, Jalud F, Kosasih H, Horne C, Brown L, El-Kamand S, et al.
Leukemia . 2023 Feb; 37(4):905-909. PMID: 36810896
No abstract available.
10.
Ryland G, Umeda M, Holmfeldt L, Lehmann S, Herlin M, Ma J, et al.
Blood . 2022 Sep; 141(7):800-805. PMID: 36179268
No abstract available.